M. G. Spillantini

4.0k citations

29 papers · 2.9k indexed · 1 hit paper · h-index 23

Physiology top 1%
Molecular Biology top 10%
Neurology top 1%
Cellular and Molecular Neuroscience top 2%
Neurology top 1%

Co-authors: Michel Goedert R. Anthony Crowther Ross Jakes Masato Hasegawa Michael J. Smith George K. Tofaris Michael V. Sofroniew Bernardino Ghetti
Topics: Alzheimer's disease research and treatments (17 papers)Parkinson's Disease Mechanisms and Treatments (10 papers)Prion Diseases and Protein Misfolding (5 papers)
Cited by: Neurology Physiology
Journals: Nature Proceedings of the National Academy of Sciences Nature Medicine
Partner nations: United Kingdom Italy United States

In The Last Decade

M. G. Spillantini

29 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

1996 825 citations Michel Goedert, Ross Jakes et al. Nature profile →

Peers

Countries citing papers authored by M. G. Spillantini

Since Specialization

Citations

This map shows the geographic impact of M. G. Spillantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. G. Spillantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. G. Spillantini more than expected).

Fields of papers citing papers by M. G. Spillantini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. G. Spillantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. G. Spillantini. The network helps show where M. G. Spillantini may publish in the future.

Co-authorship network of co-authors of M. G. Spillantini

This figure shows the co-authorship network connecting the top 25 collaborators of M. G. Spillantini. A scholar is included among the top collaborators of M. G. Spillantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. G. Spillantini. M. G. Spillantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Influence of Drug-Carrier Polymers on Alpha-Synucleinopathies: A Neglected Aspect in New Therapies Development 2018 ·BioMed Research International ·Chiara Tonda‐Turo,(unknown),Valeria Chiono,Gianluca Ciardelli,M. G. Spillantini	5
2	Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review 2014 ·Acta Neurologica Scandinavica ·Naveed Malek,Diane M.A. Swallow,Katherine A. Grosset,Oleg Anichtchik,M. G. Spillantini,Donald G. Grosset	132
3	Late-onset Parkinsonism in NF B/c-Rel-deficient mice 2012 ·Brain ·Chiara Baiguera,(unknown),Annalisa Pinna,Arianna Bellucci,Maria Antonietta De Luca,Lucia Frau,Micaela Morelli,Rosaria Ingrassia,Marina Benarese,Vanessa Porrini,(unknown),Giuseppe Bertini,Paolo Francesco Fabene,Sandra Sigala,M. G. Spillantini,Hsiou‐Chi Liou,PierFranco Spano,Marina Pizzi	68
4	Frontotemporal Dementia: Implications for Understanding Alzheimer Disease 2011 ·Cold Spring Harbor Perspectives in Medicine ·Michel Goedert,Bernardino Ghetti,M. G. Spillantini	114
5	Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson’s disease 2010 ·Journal of Neurochemistry ·Arianna Bellucci,Laura Navarria,Michela Zaltieri,(unknown),Serena Bodei,Sandra Sigala,Leontino Battistin,M. G. Spillantini,Cristina Missale,PierFranco Spano	187
6	Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis 2008 ·Brain ·JANE ANDERSON,David W. Hampton,Rickie Patani,Gareth Pryce,R. Anthony Crowther,Richard Reynolds,Robin J.M. Franklin,Gavin Giovannoni,D. A. S. Compston,David Baker,M. G. Spillantini,Siddharthan Chandran	108
7	Physiological and pathological properties of α-synuclein 2007 ·Cellular and Molecular Life Sciences ·George K. Tofaris,M. G. Spillantini	98
8	Late onset distal axonal swelling in YFP-H transgenic mice 2007 ·Neurobiology of Aging ·(unknown),(unknown),Róbert Adalbert,Elisabetta Babetto,(unknown),M. G. Spillantini,Richard R. Ribchester,Michael P. Coleman	30
9	Pattern of Tau forms in CSF is altered in progressive supranuclear palsy 2007 ·Neurobiology of Aging ·Barbara Borroni,Fabrizio Gardoni,Lucilla Parnetti,Lorenza Magno,Matteo Malinverno,(unknown),Paolo Calabresi,M. G. Spillantini,Alessandro Padovani,Mónica Di Luca	68
10	Frontotemporal lobar degeneration through loss of progranulin function 2006 ·Brain ·Michel Goedert,M. G. Spillantini	17
11	Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein 2000 ·Acta Neuropathologica ·A. Probst,Jürgen Götz,Karl‐Heinz Wiederhold,Markus Tolnay,Claudia Mistl,A.L. Jaton,Ming Hong,Takeshi Ishihara,V. M. -Y. Lee,John Q. Trojanowski,Ross Jakes,R. Anthony Crowther,M. G. Spillantini,Kurt Bürki,Michel Goedert	287
12	Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures 1999 ·Neuroscience ·(unknown),M. G. Spillantini,Michael V. Sofroniew,James W. Fawcett,J. Herbert	177
13	Tau gene mutation in familial progressive subcortical gliosis 1999 ·Nature Medicine ·Michel Goedert,M. G. Spillantini,R. Anthony Crowther,Shu G. Chen,Piero Parchi,Massimo Tabaton,Douglas J. Lanska,William R. Markesbery,Kirk C. Wilhelmsen,Dennis W. Dickson,Robert B. Petersen,Pierluigi Gambetti	145
14	Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are α-synucleinopathies 1999 ·Parkinsonism & Related Disorders ·M. G. Spillantini	67
15	Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia 1999 ·Acta Neuropathologica ·M. G. Spillantini,Markus Tolnay,Seth Love,Michel Goedert	62
16	Intraneuronal filamentous tau protein and α-synuclein deposits in neurodegenerative diseases 1998 ·Biochemical Society Transactions ·Michel Goedert,Ross Jakes,R. Anthony Crowther,Masato Hasegawa,Michael J. Smith,M. G. Spillantini	34
17	Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycansbreakdown → 1996 ·Nature ·Michel Goedert,Ross Jakes,M. G. Spillantini,Masato Hasegawa,Michael J. Smith,R. Anthony Crowther	825
18	Characterisation of an Antibody Relevant to the Neuropathology of Alzheimer Disease 1995 ·Alzheimer Disease & Associated Disorders ·Ross Jakes,Charles R. Harrington,M. G. Spillantini,Michel Goedert,A. Klug	3
19	The Synovium of Transgenic Arthritic Mice Expressing Human Tumor Necrosis Factor Contains a High Level of Nerve Growth Factor 1993 ·Growth Factors ·Luigi Aloe,Lesley Probert,George Kollias,Luisa Bracci‐Laudiero,M. G. Spillantini,Rita Levi‐Montalcini	44
20	Molecular neuropathology of Alzheimer's disease:In situ hybridization studies 1990 ·Cellular and Molecular Neurobiology ·Michel Goedert,M. G. Spillantini	10

About M. G. Spillantini

M. G. Spillantini is a scholar working on Neurology, Physiology and Aging, having authored 29 papers that have together received 2.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Prion Diseases and Protein Misfolding (5 papers). The work is most often cited by research in Neurology (567 citations), Physiology (1.7k citations) and Neurology (927 citations). M. G. Spillantini has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Michel Goedert, R. Anthony Crowther, Ross Jakes, Masato Hasegawa, Michael J. Smith, George K. Tofaris, Michael V. Sofroniew, Bernardino Ghetti, James W. Fawcett and Markus Tolnay. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact